SPX4,239.09-44.65 -1.04%
DIA337.62-2.30 -0.68%
IXIC12,750.29-215.05 -1.66%

BRIEF-Astria Therapeutics Announces FDA Clearance Of IND Application For Star-0215

BRIEF-Astria Therapeutics Announces FDA Clearance Of IND Application For Star-0215

Reuters · 07/28/2022 08:16
BRIEF-Astria Therapeutics Announces FDA Clearance Of IND Application For Star-0215

- Astria Therapeutics Inc ATXS.O:

  • ASTRIA THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR STAR-0215, A MONOCLONAL ANTIBODY INHIBITOR OF PLASMA KALLIKREIN FOR TREATMENT OF HEREDITARY ANGIOEDEMA

  • ASTRIA THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR STAR-0215, A MONOCLONAL ANTIBODY INHIBITOR OF PLASMA KALLIKREIN FOR TREATMENT OF HEREDITARY ANGIOEDEMA

Source text for Eikon: ID:

Further company coverage: ATXS.O


((Reuters.Briefs@thomsonreuters.com;))